Diozentz 5 mg/160 mg
Diozentz 5 mg/160 mg is a medicine authorised by Swissmedic under authorisation number 70536. The authorisation holder is MADDOX Pharma Swiss GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 November 2025 and the authorisation is valid without a time limit. ATC code C09DB01 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 70536 |
|---|---|
| Name | Diozentz 5 mg/160 mg |
| Full name | Diozentz 5 mg/160 mg, compresse rivestite con film |
| Authorisation holder | MADDOX Pharma Swiss GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DB01 |
| First authorisation | 17 November 2025 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Diozentz 5 mg/160 mg, compresse rivestite con film | B | 17 November 2025 |
| 2 | Diozentz 10 mg/160 mg, compresse rivestite con film | B | 17 November 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09DB01 | 02.07.2. | B |
| 2 | 28 | Tablette(n) | C09DB01 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Diozentz 5 mg/160 mg authorised in Switzerland?
Yes. Diozentz 5 mg/160 mg is authorised by Swissmedic under authorisation number 70536, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Diozentz 5 mg/160 mg have?
Diozentz 5 mg/160 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Diozentz 5 mg/160 mg?
The authorisation holder is MADDOX Pharma Swiss GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.